Exp Mol Med.  2014 Oct;46(10):e116. 10.1038/emm.2014.63.

miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6

Affiliations
  • 1Department of Dermatology, The Air Force General Hospital of PLA, Beijing, China. txg_wang@jnu.edu.cn lwei5811@126.com
  • 2Department of Radiation Oncology, The Air Force General Hospital of PLA, Beijing, China.
  • 3Department of Cell Biology and Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • 4Jinan University and Hong Kong Baptist University Joint Laboratory of Innovative Drug Development, Jinan University, Guangzhou, China.

Abstract

Dysregulated microRNA (miRNA) expression has a critical role in tumor development and metastasis. However, the mechanism by which miRNAs control melanoma metastasis is unknown. Here, we report reduced miR-98 expression in melanoma tissues with increasing tumor stage as well as metastasis; its expression is also negatively associated with melanoma patient survival. Furthermore, we demonstrate that miR-98 inhibits melanoma cell migration in vitro as well as metastatic tumor size in vivo. We also found that IL-6 is a target gene of miR-98, and IL-6 represses miR-98 levels via the Stat3-NF-kappaB-lin28B pathway. In an in vivo melanoma model, we demonstrate that miR-98 reduces melanoma metastasis and increases survival in part by reducing IL-6 levels; it also decreases Stat3 and p65 phosphorylation as well as lin28B mRNA levels. These results suggest that miR-98 inhibits melanoma metastasis in part through a novel miR-98-IL-6-negative feedback loop.


MeSH Terms

Animals
Cell Line, Tumor
Down-Regulation
Gene Expression Regulation, Neoplastic
Humans
Interleukin-6/*genetics
Male
Melanoma/epidemiology/*genetics/*pathology
Mice
Mice, Inbred C57BL
MicroRNAs/*genetics
Neoplasm Metastasis/genetics/pathology
Signal Transduction
Survival Analysis
Interleukin-6
MicroRNAs
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr